Abstract
Aimsβ-amyloid (Aβ) plaques are a key feature of Alzheimer’s disease pathology but correlate poorly with dementia. They are associated with astrocytes which may modulate the effect of Aβ-deposition on the neuropil. This study characterised the astrocyte response to Aβ plaque subtypes, and investigated their association with cognitive impairment.MethodsAβ plaque subtypes were identified in the cingulate gyrus using dual labelling immunohistochemistry to Aβ and GFAP+ astrocytes, and quantitated in two cortical areas: the area of densest plaque burden and the deep cortex near the white matter border (layer VI). Three subtypes were defined for both diffuse and compact plaques (also known as classical or core-plaques): Aβ plaque with (1) no associated astrocytes, (2) focal astrogliosis or (3) circumferential astrogliosis.ResultsIn the area of densest burden, diffuse plaques with no astrogliosis (β = -0.05, p = 0.001) and with focal astrogliosis (β = -0.27, p = 0.009) significantly associated with lower MMSE scores when controlling for sex and age at death. In the deep cortex (layer VI), both diffuse and compact plaques without astrogliosis associated with lower MMSE scores (β = -0.15, p = 0.017 and β = -0.81, p = 0.03, respectively). Diffuse plaques with no astrogliosis in layer VI related to dementia status (OR = 1.05, p = 0.025). In the area of densest burden, diffuse plaques with no astrogliosis or with focal astrogliosis associated with increasing Braak stage (β = 0.01, p<0.001 and β = 0.07, p<0.001, respectively), and ApoEε4 genotype (OR = 1.02, p = 0.001 and OR = 1.10, p = 0.016, respectively). In layer VI all plaque subtypes associated with Braak stage, and compact amyloid plaques with little and no associated astrogliosis associated with ApoEε4 genotype (OR = 1.50, p = 0.014 and OR = 0.10, p = 0.003, respectively).ConclusionsReactive astrocytes in close proximity to either diffuse or compact plaques may have a neuroprotective role in the ageing brain, and possession of at least one copy of the ApoEε4 allele impacts the astroglial response to Aβ plaques.
Highlights
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterised by β-amyloid (Aβ) plaques and intracellular tangles of hyperphosphorylated tau [1]
Reactive astrocytes in close proximity to either diffuse or compact plaques may have a neuroprotective role in the ageing brain, and possession of at least one copy of the ApoEε4 allele impacts the astroglial response to Aβ plaques
Recent studies have further characterised the astroglial response in AD, demonstrating an increase in plaque-associated GFAPα and GFAPδ isoforms, and the number of astrocytes expressing the glial fibrillary acidic protein (GFAP)(+1) isoform correlates with AD progression, they are not associated with plaques [12]
Summary
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterised by β-amyloid (Aβ) plaques (diffuse and compact dense-core) and intracellular tangles of hyperphosphorylated tau [1]. While astrocytes have been shown to play a significant role in the degradation and clearance of Aβ suggesting a neuroprotective role [13], other studies have shown astrocyte activation results in the production of critical inflammatory mediators, suggesting they play a detrimental role in the progression of age-related neurodegenerative pathology [14]. Recent studies have further characterised the astroglial response in AD, demonstrating an increase in plaque-associated GFAPα and GFAPδ isoforms, and the number of astrocytes expressing the GFAP(+1) isoform correlates with AD progression, they are not associated with plaques [12]. ApoE4, primarily expressed by astrocytes in the brain, plays a role in the metabolism of amyloid [26,27], and has been shown to promote Aβ deposition [28]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.